Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 194.6 million compared to CNY 272.4 million a year ago. Revenue was CNY 194.6 million compared to CNY 272.4 million a year ago.

Net income was CNY 74.7 million compared to CNY 40.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.12. Diluted earnings per share from continuing operations was CNY 0.12.